This inventor holds 2 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Liat Hayardeny: Innovator in Neurological Treatments
Introduction
Liat Hayardeny is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of neurology, particularly in the treatment of multiple sclerosis and related disorders. With a total of 2 patents, her work focuses on innovative methods to enhance patient care and treatment outcomes.
Latest Patents
Hayardeny's latest patents include groundbreaking inventions aimed at improving the lives of individuals suffering from neurological conditions. One of her notable patents is for "Genetic markers predictive of response to glatiramer acetate." This invention provides a method for treating patients afflicted with multiple sclerosis using a pharmaceutical composition that includes glatiramer acetate. The method outlines specific steps to ensure effective treatment for those experiencing symptoms of multiple sclerosis.
Another significant patent is titled "Treatment of BDNF-related disorders using laquinimod." This application details a method for increasing brain-derived neurotrophic factor (BDNF) serum levels in patients. It involves the periodic administration of laquinimod or its pharmaceutically acceptable salts to enhance BDNF levels, which is crucial for treating BDNF-related diseases. The patent also discusses the potential for combining laquinimod with other BDNF-increasing agents to optimize treatment efficacy.
Career Highlights
Throughout her career, Liat Hayardeny has worked with leading pharmaceutical companies, including Teva Pharmaceutical Industries Limited and Active Biotech AB. Her experience in these organizations has allowed her to develop and refine her innovative approaches to neurological treatments.
Collaborations
Hayardeny has collaborated with notable professionals in her field, including Amir Tchelet and Michael Hayden. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Liat Hayardeny is a trailblazer in the field of neurology, with her patents reflecting her commitment to improving treatment options for patients with multiple sclerosis and related disorders. Her innovative work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile